Industry News

  • 2409-2021

    On new recommendation for treatment of COVID-19 patients: WHO calls for equitable access to casirivimab and imdevimab for COVID-19

    The World Health Organization (WHO) welcomes the addition of another therapeutic to the world’s arsenal against COVID-19, but urges producing companies and governments to address the high price and limited production of the Regeneron antibody combination and ensure safe and appropriate handling of the medicine.

  • 2209-2021

    WHO calls on world leaders at the UN General Assembly to focus on vaccine equity, pandemic preparedness, and getting the SDGs back on track

    WHO is urging leaders attending the 76th session of the United Nations General Assembly (UNGA) to guarantee equitable access to COVID-19 vaccines and other life-saving tools; ensure the world is better prepared to respond to future pandemics; and renew efforts to achieve the Sustainable Development Goals (SDGs).

  • 1609-2021

    Leaders Make Urgent Call To Accelerate Vaccination Globally And In Africa

    WHO Director-General Dr Tedros Adhanom Ghebreyesus and a group of global health leaders today issued an urgent call for vaccine equity globally and in Africa in particular. The leaders stressed that the worst pandemic in the last hundred years will not end unless and until, there is genuine global cooperation on vaccine supply and access. They also reiterated the WHO’s global vaccination target for 70% of the population of all countries to be vaccinated by mid- 2022.

  • 1309-2021

    How vaccines can help to prevent antibiotic resistance - Zimbabwe’s response to drug-resistant outbreaks of typhoid and cholera

    Antibiotic resistance is a natural phenomenon that happens when bacteria develop the ability to defeat the drugs designed to kill them. The germs change over time, no longer responding to medicines thus making infections harder, and sometimes impossible, to treat. This, in turn, results in higher health care costs for both individuals and governments. “Preventing and controlling antibiotic resistance calls for a multi-pronged approach, of which vaccines is one”, says Dr Stanley Midzi, WHO Health Systems Strengthening Advisor.

  • 1009-2021

    Upcoming WHO Consultation on the Composition of Influenza Virus Vaccines for the Southern Hemisphere 2022

    We wish to inform you that the WHO Consultation on the Composition of Influenza Virus Vaccines for Use in the 2022 Southern Hemisphere Influenza Season will take place virtually from 13-23 September 2021, followed by an Information Meeting on the 24 September 2021, with vaccine manufacturers and national vaccine regulatory agencies. More information is available on the website here. The WHO recommendation will be based on the analysis of recent influenza viruses worldwide.

  • 0809-2021

    New World Food Safety Day Report highlights a year-round effort to promote and ensure safe food for all

    On 7 September 2021 WHO and FAO jointly released the annual World Food Safety Day report highlighting around 300 different events organized around the world on the occasion of World Food Safety Day (7 June 2021). Celebrations were held in 90 countries by international organizations, governments, businesses, non-governmental organizations, academics and individuals.

  • 0609-2021

    Virtual cGMP Training Marathon for vaccine manufacturing

    Many low- and middle-income countries (LMICs) face inconsistent supply of quality-assured vaccines and are therefore dependent on importation to fill the gaps in supply. It is recognized that local production can improve timely access and safeguard health security in vaccine supplies.

  • 0209-2021

    WHO releases new compendium of innovative health technologies for COVID-19 and other priority diseases

    The COVID-19 pandemic has highlighted the need for innovative health technologies that can help countries improve health outcomes by providing shortcuts to solutions despite lack of infrastructure and resources. However, many of the new technologies that have come to market are unaffordable or unsuitable for low- and middle-income countries.

  • 3108-2021

    Joint Statement of the Multilateral Leaders Taskforce on Scaling COVID-19 Tools

    At its third meeting, the Multilateral Leaders Taskforce on COVID-19 (MLT), the heads of the International Monetary Fund, World Bank Group, World Health Organization and World Trade Organization - met with the leaders of the African Vaccine Acquisition Trust (AVAT), Africa CDC, Gavi and UNICEF to tackle obstacles to rapidly scale-up vaccines in low- and lower middle-income countries, particularly in Africa, and issued the following statement:

  • 2708-2021

    WHO issues rapid communication on updated guidance for the management of TB in children and adolescents

    A rapid communication released by the World Health Organization (WHO) Global Tuberculosis Programme has announced important updates to guidance on the management of tuberculosis (TB) in children and adolescents. This includes new recommendations on diagnostic options, treatment regimens, as well as treatment decision algorithms and optimal models of care for the delivery of child and adolescent TB services.

Get the latest price? We'll respond as soon as possible(within 12 hours)

Privacy policy